Docencia
Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study
Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía
Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant
Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/Hepatitis C virus-coinfected patients
Dr. Juan Luis Gómez Sirvent. Sección de infecciones. Hospital Universitario de Canarias, Santa Cruz de Tenerife
Birth outcomes for pregnant women with HIV using Tenofovir-Emtricitabine
Dra. Carmen Hidalgo. FEA de la Unidad de Gestión Clínica de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada
A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in adults with human immunodeficiency virus infection: an aids malignancy consortium trial
Dra. María Saumoy. Unidad de VIH y ETS. Servicio de Enfermedades Infecciosas. Hospital Universitario de Bellvitge, Barcelona
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/ml
Dr.Pablo Ryan. Servicio de Medicina Interna. Hospital Universitario Infanta Leonor. Madrid
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
Dr. Enrique Bernal. Unidad de Enfermedades Infecciosas. Hospital General Universitario Reina Sofía.
Phase 3 study of Ibalizumab for multidrug-resistant HIV-1
Dra. Luz Martín Carbonero. Medicina Interna. Hospital Universitario La Paz, Madrid.
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults HIV-1 (DRIVE-FORWARD): 48- week results of a randomised, double-blind, phase 3, non inferiority trial
Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella
Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial
Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.
Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV
Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial
Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona
Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIVUninfected Adults in the United States: A Cross-Sectional Study
Dra. Ana Mariño. Unidad de VIH. Hospital Arquitecto Marcide-Novoa Santos, A Coruña.
Non Antiretrocial Polypharmacy and Adverse Health Outcomes Amon HIV. Infected and Uninfected Individuals
Dr. Julián Olalla Sierra. Especialista en Medicina Interna Hospital Costa del Sol, Marbella
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial
Dra. Marta Montero Alonso. Unidad de Enfermedades Infecciosas. Hospital Universitario y Politécnico la Fe, Valencia.
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
Dra. Matilde Sánchez Conde. Infectious Diseases Unit. Hospital Ramón y Cajal, Madrid
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance ofHIV viral suppression in patients with high cardiovascular
Dr. Esteban Martínez. Infectious Diseases Unit. Hospital Clínic, University of Barcelona
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review andmeta-regression analysis
Dr. Arkaitz Imaz. Servicio de Enfermedades Infecciosas Hospital Universitario de Bellvitge, Barcelona
